Yousheng Mao

TL;DR: The current evolution of the epidemiologic characteristics of lung cancer and its relative risk factors are reviewed to explore new ways of diagnosis and treatment.

TL;DR: Wang et al. as mentioned in this paper carried out a comprehensive proteomics analysis of 103 cases of lung adenocarcinoma (LUAD) in Chinese patients and revealed cancer-associated characteristics, such as tumorassociated protein variants, distinct proteomics features, and clinical outcomes in patients at an early stage or with EGFR and TP53 mutations.

TL;DR: Neoadjuvant sintilimab was tolerable for patients with NSCLC, and 40.5% MPR rate is encouraging, and the decrease of maximum standardized uptake values after sintILimab might predict pathologic response.

TL;DR: It is concluded that miR-33a can attenuate NSCLC cells proliferation via targeting to the 3'UTR of METTL3 mRNA via in silico prediction, which provides new insights into the mechanism ofMETTL3 regulation by micro RNA, and supports MET TL3 as a therapeutic target inNSCLC.

TL;DR: The differentially expressed clusterin may play a key role during tumorigenesis of ESCC and is one of the powerful tools for discovery of secreted markers from peripheral in the 2DE-MS based proteomic approach.